P-n-T Data Corp. Announces Full Board of Directors and Executive Leadership Team

4 months ago

Leadership depth reinforces the company's mission to modernize healthcare data sharing with speed, security, and control MIDDLETOWN, CT / ACCESS…

Bausch Health’s OraPharma Introduces “OraTalks,” a New Podcast Bringing Bold Conversations to Dentistry

4 months ago

Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue.Nine-episode inaugural season hosted by industry thought…

The Keloid Plastic Surgery Center Discusses How to Treat Ear Keloids From Piercings and Trauma

4 months ago

Board-certified surgeons Dr. Gabriel Salloum and Dr. Roberto Mendez share insights into ear keloid treatment, emphasizing personalized care plans that…

Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

4 months ago

SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"),…

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

4 months ago

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the…

Avant Brands Recognized as One of Canada’s Top Growing Companies by The Globe and Mail for Third Consecutive Year

4 months ago

KELOWNA, B.C. / ACCESS Newswire / September 29, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading…

Outlook Therapeutics Provides Update on Type A Meeting with FDA

4 months ago

ISELIN, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.  (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the…

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

4 months ago

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares YAVNE, Israel, September 29, 2025 -- MediWound Ltd. (Nasdaq: MDWD)…

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

4 months ago

Data show results consistent with clinical trial experienceA high level of safety – no device-related adverse eventsStrong survival data extending…

Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy

4 months ago

- Data from ongoing DELIVER trial demonstrated sustained functional improvement through 18 months; results from Registrational Expansion Cohort expected late…